+44 (0) 1223 755950
+1 832 327 7413
Orders to United States ship from United States
Target | Cytomegalovirus pp65 (CMV UL83) |
Origin | Virus |
Expression | Recombinant |
Tested Applications | ELISA, WB |
Host | E. coli |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Form | Liquid |
Purity | > 95% (10% PAGE, Coomassie staining) |
Purification | Purified from E. coli by GS-4B Sepharose Affinity Purification. |
Storage | Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles. |
Molecular Weight | 50 kDa |
Sequence Fragment | Contains the CMV pp65 (UL83) immunodominant regions. |
Sequence | The exact sequence is proprietary. |
Tag | GST tag |
Buffer | 25 mM Tris-HCl, pH 8, 5mM bMe, 8 M Urea. Does not contain preservatives. |
Specificity | Immunoreactive with CMV positive sera. |
Concentration | 1 mg/ml |
Availability | Shipped within 10-20 working days. |
Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |